Abstract
Objectives: Teprotumumab, a novel monoclonal antibody, targets the insulin-like growth factor 1 (IGF-1) receptor. IGF-1 receptors, found in muscle and......
小提示:本篇文献需要登录阅读全文,点击跳转登录